Microvascular function in non‐dippers: Potential involvement of the salt sensitivity biomarker, marinobufagenin—The African‐PREDICT study
Open Access
- 24 December 2019
- journal article
- research article
- Published by Wiley in The Journal of Clinical Hypertension
- Vol. 22 (1) , 86-94
Abstract
Suppressed nighttime blood pressure dipping is associated with salt sensitivity and may increase the hemodynamic load on the microvasculature. The mechanism remains unknown whereby salt sensitivity may increase the cardiovascular risk of non‐dippers. Marinobufagenin, a novel steroidal biomarker, is associated with salt sensitivity and other cardiovascular risk factors independent of blood pressure. The authors investigated whether microvascular function in non‐dippers is associated with marinobufagenin. The authors included 220 dippers and 154 non‐dippers (aged 20‐30 years) from the African‐PREDICT study, with complete 24‐hour urinary marinobufagenin and sodium data. The authors determined dipping status using 24‐hour blood pressure monitoring and defined nighttime non‐dipping .05). However, only in non‐dippers did peak retinal artery dilation relate negatively to marinobufagenin excretion after single (r = −0.20; P = .012), partial (r = −0.23; P = .004), and multivariate‐adjusted regression analyses (Adj. R2 = 0.34; β = −0.26; P < .001). The authors also noted a relationship between peak artery dilation and estimated salt intake (Adj. R2 = 0.30; β = −0.14; P = .051), but it was lost upon inclusion of marinobufagenin (Adj. R2 = 0.33; β = −0.015; P = .86). No relationship between microvascular reactivity and marinobufagenin was evident in dippers (P = .77). Marinobufagenin, representing salt sensitivity, may be involved in early microvascular functional changes in young non‐dippers and thus contributes to the development of hypertension and cardiovascular disease later in life.Keywords
Funding Information
- Newton Fund
- Novartis Farmacéutica
This publication has 46 references indexed in Scilit:
- Salt in Health and Disease — A Delicate BalanceNew England Journal of Medicine, 2013
- Blunted Sleep-Time Relative Blood Pressure Decline Increases Cardiovascular Risk Independent of Blood Pressure Level—The “Normotensive Non-dipper” ParadoxChronobiology International, 2012
- Marinobufagenin causes endothelial cell monolayer hyperpermeability by altering apoptotic signalingAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2009
- Correlation of Flicker-Induced and Flow-Mediated Vasodilatation in Patients With Endothelial Dysfunction and Healthy VolunteersDiabetes Care, 2009
- Endogenous Cardiotonic Steroids and Differential Patterns of Sodium Pump Inhibition in NaCl-Loaded Salt-Sensitive and Normotensive RatsAmerican Journal of Hypertension, 2009
- Endogenous Cardiotonic Steroids: Physiology, Pharmacology, and Novel Therapeutic TargetsPharmacological Reviews, 2009
- Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertensionJournal Of Hypertension, 2008
- Retinal Vascular Caliber, Cardiovascular Risk Factors, and Inflammation: The Multi-Ethnic Study of Atherosclerosis (MESA)Investigative Ophthalmology & Visual Science, 2006
- Marinobufagenin, an Endogenous α-1 Sodium Pump Ligand, in Hypertensive Dahl Salt-Sensitive RatsHypertension, 2001
- Salt Sensitivity, Pulse Pressure, and Death in Normal and Hypertensive HumansHypertension, 2001